Abstract
Herein, an integrated approach based on immunoassay and exonuclease III-assisted nucleic acid amplification (EANA), which is defined as exonuclease III-assisted nucleic acid amplification fluorescence immunoassay (EA-NAFIA) was developed for the detection of chloramphenicol (CAP). Au nanoparticles (AuNPs) modified with antibody and DNA were used as bifunctional probe, in which antibody captured the target, and DNA initiated the signal amplification through EANA. A detection linear range from 0.01 to 5 ng/L was obtained under optimized conditions, and the detection limit was as low as 0.001 ng/L. There was no cross reaction with streptomycin, kanamycin, gentamicin, thiamphenicol. This assay was successfully applied to detect CAP in skim milk, with acceptable recoveries. This kind of integrated strategy demonstrated the excellent hybrid performance of indirect immunoassay with ultrasensitive sensitivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
